Article
Low expression of CRISP3 predicts a favorable prognosis in patients with mammary carcinoma
4 Jan 2019
Abstract excerpt
The discovery of cysteine-rich secretory protein 3 (CRISP3) has been made in human neutrophils for the first time. Cloning of the complementary DNA (cDNA) for CRISP3 was performed from a cDNA library of human bone marrow. In patients with mammary carcinoma, we found that lower expression of CRISP3 was connected to a significantly improved DFS (disease-free survival) and OS (overall survival). Furthermore, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
